L 758298: Clinical Trials

1 trial of L 758298, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow L 758298: new trials by email Literature Review of L 758298 trials Research Report on L 758298

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX
aprepitant, dexamethasone, fluorouracil - Colorectal Cancer, Nausea and Vomiting
Phase 2CompletedOHSU Knight Cancer Institute542006-06-012017-06-12

Conditions studied

Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Nausea (1)  ·  Rectal Neoplasms (1)  ·  Vomiting (1)

Sponsors

OHSU Knight Cancer Institute (1)

Countries

United States (1)

Top investigators

Joseph Bubalo, PharmD, BCPS, BCOP (1)